MetaCap

TriSalus Life Sciences Insider Trades

NASDAQ: TLSIHealth CareMedical SpecialitiesUSD

4.06-0.07 (-1.69%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
3 · $4.11K
Shares bought / sold
0 / 937
Net activity
Net selling $4,113

TriSalus Life Sciences insider activity

Over the last 12 months, TriSalus Life Sciences insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $4,113 worth of stock, for net insider selling of $4,113. The largest seller was Marshak Richard, with $1,427 in reported sales.

The most recent filing shows Stevens Jennifer (Chief Regulatory Officer) selling 316 shares at $4.39 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TLSI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TLSI insider transactions

TriSalus Life Sciences insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Cox Bryan F.Chief of ResearchSale296$1.30KForm 4
Oct 5, 2026Marshak RichardChief Commercial OfficerSale325$1.43KForm 4
Oct 5, 2026Szela Mary TCEO and PresidentTax withholding2,693$11.80KForm 4
Oct 5, 2026Stevens JenniferChief Regulatory OfficerSale316$1.39KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related